These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 1446008
21. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human placental microsomes. Collazo NR, Sultatos LG. Biochem Pharmacol; 1995 Nov 27; 50(11):1933-41. PubMed ID: 8615875 [Abstract] [Full Text] [Related]
22. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Rioux N, Castonguay A. Cancer Res; 1998 Dec 01; 58(23):5354-60. PubMed ID: 9850065 [Abstract] [Full Text] [Related]
23. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Smith TJ, Stoner GD, Yang CS. Cancer Res; 1995 Dec 01; 55(23):5566-73. PubMed ID: 7585636 [Abstract] [Full Text] [Related]
24. Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice. Guo Z, Smith TJ, Wang E, Eklind KI, Chung FL, Yang CS. Carcinogenesis; 1993 Jun 01; 14(6):1167-73. PubMed ID: 8508504 [Abstract] [Full Text] [Related]
25. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver. Schrader E, Hirsch-Ernst KI, Richter E, Foth H. Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar 01; 357(3):336-43. PubMed ID: 9550307 [Abstract] [Full Text] [Related]
26. Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung. Atalla A, Maser E. Toxicology; 1999 Nov 29; 139(1-2):155-66. PubMed ID: 10614696 [Abstract] [Full Text] [Related]
27. Effects of long term dietary phenethyl isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Staretz ME, Koenig LA, Hecht SS. Carcinogenesis; 1997 Sep 29; 18(9):1715-22. PubMed ID: 9328166 [Abstract] [Full Text] [Related]
28. Evidence for an important role of DNA pyridyloxobutylation in rat lung carcinogenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: effects of dose and phenethyl isothiocyanate. Staretz ME, Foiles PG, Miglietta LM, Hecht SS. Cancer Res; 1997 Jan 15; 57(2):259-66. PubMed ID: 9000565 [Abstract] [Full Text] [Related]
29. Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. Castonguay A, Pepin P, Stoner GD. Exp Lung Res; 1991 Jan 15; 17(2):485-99. PubMed ID: 2050045 [Abstract] [Full Text] [Related]
30. Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. Hecht SS, Trushin N, Rigotty J, Carmella SG, Borukhova A, Akerkar S, Rivenson A. Cancer Epidemiol Biomarkers Prev; 1996 Aug 15; 5(8):645-52. PubMed ID: 8824368 [Abstract] [Full Text] [Related]
31. Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung. Pepin P, Bouchard L, Nicole P, Castonguay A. Carcinogenesis; 1992 Mar 15; 13(3):341-8. PubMed ID: 1547522 [Abstract] [Full Text] [Related]
32. Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes. Staretz ME, Murphy SE, Patten CJ, Nunes MG, Koehl W, Amin S, Koenig LA, Guengerich FP, Hecht SS. Drug Metab Dispos; 1997 Feb 15; 25(2):154-62. PubMed ID: 9029045 [Abstract] [Full Text] [Related]
33. Cell specificity for the pulmonary metabolism of tobacco-specific nitrosamines in the Fischer rat. Belinsky SA, White CM, Trushin N, Hecht SS. Carcinogenesis; 1989 Dec 15; 10(12):2269-74. PubMed ID: 2591016 [Abstract] [Full Text] [Related]
34. Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Zhang Z, Hamilton SM, Stewart C, Strother A, Teel RW. Anticancer Res; 1993 Dec 15; 13(6A):2341-6. PubMed ID: 8297156 [Abstract] [Full Text] [Related]
35. Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. Zhou X, D'Agostino J, Xie F, Ding X. J Pharmacol Exp Ther; 2012 Apr 15; 341(1):233-41. PubMed ID: 22262919 [Abstract] [Full Text] [Related]
36. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Smith TJ, Guo Z, Guengerich FP, Yang CS. Carcinogenesis; 1996 Apr 15; 17(4):809-13. PubMed ID: 8625495 [Abstract] [Full Text] [Related]
37. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in peripheral human lung microsomes. Smith GB, Bend JR, Bedard LL, Reid KR, Petsikas D, Massey TE. Drug Metab Dispos; 2003 Sep 15; 31(9):1134-41. PubMed ID: 12920169 [Abstract] [Full Text] [Related]
38. Effects of intragastrically administered Pycnogenol on NNK metabolism in F344 rats. Huynh HT, Teel RW. Anticancer Res; 1999 Sep 15; 19(3A):2095-9. PubMed ID: 10470154 [Abstract] [Full Text] [Related]
39. Effects of dietary 1,4-phenylenebis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats. Prokopczyk B, Cox JE, Upadhyaya P, Amin S, Desai D, Hoffmann D, el-Bayoumy K. Carcinogenesis; 1996 Apr 15; 17(4):749-53. PubMed ID: 8625486 [Abstract] [Full Text] [Related]
40. The essential role of the functional group in alkyl isothiocyanates for inhibition of tobacco nitrosamine-induced lung tumorigenesis. Jiao D, Smith TJ, Kim S, Yang CS, Desai D, Amin S, Chung FL. Carcinogenesis; 1996 Apr 15; 17(4):755-9. PubMed ID: 8625487 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]